215 related articles for article (PubMed ID: 29656365)
21. AAV8 capsid variable regions at the two-fold symmetry axis contribute to high liver transduction by mediating nuclear entry and capsid uncoating.
Tenney RM; Bell CL; Wilson JM
Virology; 2014 Apr; 454-455():227-36. PubMed ID: 24725949
[TBL] [Abstract][Full Text] [Related]
22. Recent Advances in the Analysis Full/Empty Capsid Ratio and Genome Integrity of Adeno-associated Virus (AAV) Gene Delivery Vectors.
Hajba L; Guttman A
Curr Mol Med; 2020; 20(10):806-813. PubMed ID: 32748744
[TBL] [Abstract][Full Text] [Related]
23. Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.
Warrington KH; Gorbatyuk OS; Harrison JK; Opie SR; Zolotukhin S; Muzyczka N
J Virol; 2004 Jun; 78(12):6595-609. PubMed ID: 15163751
[TBL] [Abstract][Full Text] [Related]
24. Direct Liquid Chromatography/Mass Spectrometry Analysis for Complete Characterization of Recombinant Adeno-Associated Virus Capsid Proteins.
Jin X; Liu L; Nass S; O'Riordan C; Pastor E; Zhang XK
Hum Gene Ther Methods; 2017 Oct; 28(5):255-267. PubMed ID: 28627251
[TBL] [Abstract][Full Text] [Related]
25. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
26. Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype.
Grimm D; Pandey K; Nakai H; Storm TA; Kay MA
J Virol; 2006 Jan; 80(1):426-39. PubMed ID: 16352567
[TBL] [Abstract][Full Text] [Related]
27. Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences.
Aurnhammer C; Haase M; Muether N; Hausl M; Rauschhuber C; Huber I; Nitschko H; Busch U; Sing A; Ehrhardt A; Baiker A
Hum Gene Ther Methods; 2012 Feb; 23(1):18-28. PubMed ID: 22428977
[TBL] [Abstract][Full Text] [Related]
28. OneBac 2.0: Sf9 Cell Lines for Production of AAV1, AAV2, and AAV8 Vectors with Minimal Encapsidation of Foreign DNA.
Mietzsch M; Hering H; Hammer EM; Agbandje-McKenna M; Zolotukhin S; Heilbronn R
Hum Gene Ther Methods; 2017 Feb; 28(1):15-22. PubMed ID: 28125901
[TBL] [Abstract][Full Text] [Related]
29. Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant -7m8.
Khabou H; Desrosiers M; Winckler C; Fouquet S; Auregan G; Bemelmans AP; Sahel JA; Dalkara D
Biotechnol Bioeng; 2016 Dec; 113(12):2712-2724. PubMed ID: 27259396
[TBL] [Abstract][Full Text] [Related]
30. High-throughput screening and biophysical interrogation of hepatotropic AAV.
Murphy SL; Bhagwat A; Edmonson S; Zhou S; High KA
Mol Ther; 2008 Dec; 16(12):1960-7. PubMed ID: 18827805
[TBL] [Abstract][Full Text] [Related]
31. Adeno-Associated Virus (AAV) Capsid Stability and Liposome Remodeling During Endo/Lysosomal pH Trafficking.
Lins-Austin B; Patel S; Mietzsch M; Brooke D; Bennett A; Venkatakrishnan B; Van Vliet K; Smith AN; Long JR; McKenna R; Potter M; Byrne B; Boye SL; Bothner B; Heilbronn R; Agbandje-McKenna M
Viruses; 2020 Jun; 12(6):. PubMed ID: 32575696
[TBL] [Abstract][Full Text] [Related]
32. Significant Differences in Capsid Properties and Potency Between Adeno-Associated Virus Vectors Produced in Sf9 and HEK293 Cells.
Giles A; Lock M; Chen SJ; Turner K; Wesolowski G; Prongay A; Petkov BN; Olagbegi K; Yan H; Wilson JM
Hum Gene Ther; 2023 Oct; 34(19-20):1003-1021. PubMed ID: 37597192
[TBL] [Abstract][Full Text] [Related]
33. Quantification of adeno-associated virus particles and empty capsids by optical density measurement.
Sommer JM; Smith PH; Parthasarathy S; Isaacs J; Vijay S; Kieran J; Powell SK; McClelland A; Wright JF
Mol Ther; 2003 Jan; 7(1):122-8. PubMed ID: 12573625
[TBL] [Abstract][Full Text] [Related]
34. Adeno-Associated Virus Vector Design-Moving the Adeno-Associated Virus to a Bioengineered Therapeutic Nanoparticle.
Jäschke N; Büning H
Hematol Oncol Clin North Am; 2022 Aug; 36(4):667-685. PubMed ID: 35778330
[TBL] [Abstract][Full Text] [Related]
35. Effect of genome size on AAV vector packaging.
Wu Z; Yang H; Colosi P
Mol Ther; 2010 Jan; 18(1):80-6. PubMed ID: 19904234
[TBL] [Abstract][Full Text] [Related]
36. Analytical characterization of full, intermediate, and empty AAV capsids.
McColl-Carboni A; Dollive S; Laughlin S; Lushi R; MacArthur M; Zhou S; Gagnon J; Smith CA; Burnham B; Horton R; Lata D; Uga B; Natu K; Michel E; Slater C; DaSilva E; Bruccoleri R; Kelly T; McGivney JB
Gene Ther; 2024 May; 31(5-6):285-294. PubMed ID: 38374348
[TBL] [Abstract][Full Text] [Related]
37. Probing the Link among Genomic Cargo, Contact Mechanics, and Nanoindentation in Recombinant Adeno-Associated Virus 2.
Zeng C; Moller-Tank S; Asokan A; Dragnea B
J Phys Chem B; 2017 Mar; 121(8):1843-1853. PubMed ID: 28142241
[TBL] [Abstract][Full Text] [Related]
38. Characterization and biodistribution of under-employed gene therapy vector AAV7.
Yost SA; Firlar E; Glenn JD; Carroll HB; Foltz S; Giles AR; Egley JM; Firnberg E; Cho S; Nguyen T; Henry WM; Janczura KJ; Bruder J; Liu Y; Danos O; Karumuthil-Melethil S; Pannem S; Yost V; Engelson Y; Kaelber JT; Dimant H; Smith JB; Mercer AC
J Virol; 2023 Nov; 97(11):e0116323. PubMed ID: 37843374
[TBL] [Abstract][Full Text] [Related]
39. Modification and labeling of AAV vector particles.
Büning H; Bolyard CM; Hallek M; Bartlett JS
Methods Mol Biol; 2011; 807():273-300. PubMed ID: 22034035
[TBL] [Abstract][Full Text] [Related]
40. Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors.
Varadi K; Michelfelder S; Korff T; Hecker M; Trepel M; Katus HA; Kleinschmidt JA; Müller OJ
Gene Ther; 2012 Aug; 19(8):800-9. PubMed ID: 21956692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
